USPTO serial 79327147
PROXYGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 21, 2023
- Examiner
- KHOURI, SANI PHILIPPE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PROXYGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Claudia W. Stangle
Claudia W. Stangle Leydig, Voit & Mayer Ltd.180 N. Stetson Ave, STE 4900Two Prudential PlazaChicago, IL 60601-6745Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes; molecules for use in industry, namely, protein-modulating molecules for use in the pharmaceutical industry; molecules for use in science, namely, protein-modulating molecules for use in the pharmaceutical industry; molecules for molecular biology, other than for medical or veterinary use, namely, protein-modulating molecules for use in the pharmaceutical industry | ACTIVE | — |
| 005 | Pharmaceutical and therapeutic preparations for the treatment of cancer, immunological diseases, inflammatory diseases, neurological diseases, and genetic disorders; pharmaceutical and therapeutic preparations for modulating protein degradation pathways | ACTIVE | — |
| 042 | Scientific research and development services; scientific research of protein degradation; discovery and development of protein degradation pathway modulating molecules, namely, scientific research services; scientific research of protein ubiquitination; discovery and development of proximity-inducing agents, namely, scientific research services; research and development of proteolysis targeting chimeras; research and development of ligase-mediated protein modifications; discovery and development of molecular glue degraders, namely, scientific research services; discovery and development of monovalent protein degraders, namely, scientific research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Proxygen GmbH
- Other trademarks owned by Proxygen GmbH
- Other trademarks owned by Proxygen GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named PROXYGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 13, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 24, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 24, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 21, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 6, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 6, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 23, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 2, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 29, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 8, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 7, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 2, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |